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Abstract
Background: The Educational Needs Assessment Tool (the ENAT) is a 39-item patient questionnaire originally
developed in the UK to assess educational needs of patients with rheumatoid arthritis (RA). The objective of this
study was to assess the cross-cultural validity of the ENAT in 7 European countries.
Methods: The ENAT was translated into Dutch, Finnish, Norwegian, Portuguese, Spanish and Swedish versions by
using Beaton’s cross-cultural adaptation process, and was completed by a convenience sample of patients with RA
in each country. The generated country-specific data were assessed for construct validity and were then pooled
and assessed for cross-cultural invariance using Rasch analysis.
Results: Individual country-specific analysis showed adequate fit to the Rasch model after adjustment for local
dependency within domains. When data from the different countries were pooled, the 39 items deviated
significantly from Rasch model’s expectations (X
2 = 977.055, DF = 351, p = 0.000, PSI = 0.976). Again, most items
within domains were found to be locally dependent, significantly affecting the fit. Consequently each domain was
treated as a unit (i.e. testlet) and the ENAT was re-analysed as a seven-testlet scale resulting into a good fit to the
Rasch model (X
2 = 71.909; DF = 63; p = 0.207, PSI = 0.951). A test of strict unidimensionality confirmed that all
domains contributed to measuring a single construct. Cross-cultural non-invariance was discounted by splitting
domains for DIF maintaining an excellent fit to the Rasch model. This allowed calibration of the ENAT into an
interval scale.
Conclusion: The ENAT is a simple tool, which is a valid measure of educational needs of people with RA.
Adjustment for cross-cultural non-invariance is available if data from the 7 European countries are to be pooled or
compared.
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Background
Rheumatoid arthritis (RA) is a chronic inflammatory,
systemic disease largely affecting the synovium, which
can lead to joint damage and bone destruction. It can
affect the heart, lungs and eyes and causes severe dis-
ability, psychological distress and increased mortality
[1,2]. Drug management aims to relieve symptoms and
to modify the disease process. Despite new biologic
treatments which are more efficacious and specific than
other drug treatments [3,4], the patients’ improvement
in health status and quality of life may depend on their
ability and willingness to adhere to all their therapies
and undertake self-care activities. Patient education is
the process by which patients are prepared for the latter
important undertaking [5].
Patient education is recommended as an integral part
of rheumatic diseases management [6,7] and ranges from
supplying patient information leaflets to well-structured
self-management programmes. However, systematic
reviews have suggested that non-targeted education does
not deliver long-term effects in RA patients [8,9]. Conse-
quently recommendations have been made for patient
education to be more patient-centred and tailored to
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any medium, provided the original work is properly cited.address individuals’ educational needs [10]. In order to
plan effective patient-tailored education, clinicians need
to assess patients’ perceptions of their educational needs.
The Educational Needs Assessment Tool (the ENAT)
is a patient-completed questionnaire designed to help
patients with rheumatoid arthritis identify their educa-
tional needs. It was originally developed with patients
and practitioners in the UK and it comprises 39 items
grouped into 7 domains, namely: managing pain
(6 items), movement (5 items), feelings (4 items), arthri-
tis process (7 items), treatments (7 items), self-help
measures (6 items) and support systems (4 items). The
items are 5-category rating scales with descriptors: “not
at all important”, “a little important”, “fairly important”,
“very important” and “extremely important”.T h i sg i v e s
a total score of educational needs ranging from 0-156.
In the early development of the ENAT, two pilot studies
were conducted among patients with various forms of
arthritis [11]. The first one (with 20 patients) found the
ENAT acceptable and easy to use and in the second
(with 97 patients) the ENAT demonstrated a good test-
retest reliability [11]. The original (English) ENAT was
later completed by a sample of 125 patients with RA in
the UK and its 7 domains demonstrated a good fit to
the Rasch model indicating a good construct validity
and supporting the unidimensionality of the scale [12].
Since patient education is a globally accepted part of
treatment in RA and given the increasing need to
undertake multinational studies, tools such as the ENAT
also need to demonstrate a cross-cultural invariance (i.e.
work in a consistent manner across countries) [13-15].
Thus cross-cultural validation of the ENAT would
enable comparison of educational needs and data pool-
ing across Europe. The objective of this research was to
assess the cross-cultural validity of the ENAT in RA in
7 European countries.
Methods
Patients
This multicentre quantitative survey involved patients
from the Netherlands, Finland, Norway, Portugal, Spain,
Sweden and the UK. Each country was asked to provide
at least 125 patients in order to achieve the minimum
sample size recommended for Rasch analysis [16]. Apart
from the Netherlands and Sweden, which used random
sampling, all centres utilised convenience sampling
methods to recruit patients from their rheumatology
clinics, wards, day hospitals and databases. The inclu-
sion criteria were age 18 or above, a positive diagnosis
of RA and willingness to complete the ENAT. The
exclusion criteria were (a) having any other rheumatic
disease such as systemic lupus erythematosus, systemic
sclerosis, psoriatic arthritis, ankylosing spondylitis and
osteoarthritis, (b) inability to read or write and (c) those
unwilling to participate. Participation was voluntary and
each centre obtained an ethical approval from their
local ethics committees.
Measure
The original (English) ENAT was translated into the
respective language versions by using the cross-cultural
adaptation process recommended by Beaton et al [17].
The adaptation process involved 5 steps: 1) Initial
translation - from the original (English) language to the
target language 2) synthesis of the translations 3) back
(blind) translation into the original (English) language 4)
expert committee review which decides on equivalence
between the source and target versions and 5) test of
the pre-final version - testing the “adapted” version with
30 patients. This process was facilitated by an initial
“set-up” meeting where the parameters for adaptation
were considered and formalised. At this meeting,
emphasis was placed upon the importance of the “con-
ceptual” meaning of the statements in the ENAT.
The translated versions of the ENAT were given to
patients in their respective countries to complete as
postal surveys, or before their clinic consultations. The
ENATs were anonymous but contained patients’
demographical data such as gender, age, educational
background and self-reported disease duration.
Statistical analysis
Rasch analysis was used to assess the construct validity
and the cross-cultural invariance of the ENAT [18].
Rasch analysis has been used in rheumatology in the
development of new scales [19,20], to test the psycho-
metric properties of existing scales [21,22] and for
cross-cultural validation of patient outcome measures
[14,23,24]. Since the Rasch model provides formal repre-
sentation of fundamental measurement; fit to the model
implies a criterion-related construct validity [25], objec-
tivity [26], reliability [27] and statistical sufficiency [28].
Given fit to the Rasch model, ordinal data from an
instrument can be converted into an interval scale, and
parametric analytical methods can be used [29]. A more
detailed description of the Rasch measurement model
and its use in rheumatology is given elsewhere [30].
In the current study, data from individual countries
were analysed separately and as pooled data, and sub-
jected to Rasch analysis using RUMM2020 software
[31]. Since the response format of the ENAT is polyto-
mous, we utilised the Masters Partial Credit Model
parameterisation [32]. Both the country-specific datasets
and pooled data were assessed for fit, reliability and
unidimensionality. The ideal fit values are given at the
bottom of the Rasch analysis results table. In addition,
the residual correlation matrix was examined and items
that had a correlation of ± 0.3 were considered to
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items were combined into a “testlet”. A testlet is defined
as a subset of items that is treated as a measurement
unit in test construction, administration and/or scoring
[34]. The data, in the form of testlets were then tested
for fit, unidimensionality and invariance. Strict unidi-
mensionality was assessed by analysis of the principal
components of the standardised residuals, the loadings
upon which give rise to two sets of items to generate
independent estimates, which are then compared using
the independent t-test method suggested by Smith [35].
The reliability of the ENAT was assessed by Person
Separation Index (PSI) which provides the estimate of
the internal consistency of the scale using the logit value
for each person as opposed to the raw score used in
Cronbach’s alpha [36].
The test of invariance (DIF analysis) was based on
person factors such as gender, age, disease duration,
educational background and country. To allow for com-
parisons, the continuous data (age and disease duration)
were converted into categorical variables by splitting
them at their country-specific medians. Education was
categorised as basic (up to secondary education) or
higher (high school - university) education. Item charac-
teristic curves for each testlet were checked for any
significant DIF with respect to any person factor. Since
there were 7 countries, post-hoc analysis of cross-
cultural DIF (Tukey test) was performed to ascertain
cross-cultural DIF patterns. Subsequently the testlets
affected with uniform DIF were “split” for DIF in order
to adjust for the bias [37]. To avoid type I errors due to
multiple testing, the p-values for fit statistics and
DIF analyses were Bonferroni-adjusted to the alpha level
(i.e. p = 0.05/number of tests carried out) [38].
Results
Sample characteristics
The sample of 1042 comprised 135 patients from
Finland, 165 from the Netherlands, 137 from Norway,
1 2 3f r o mP o r t u g a l ,2 3 0f r o mS p a i n ,1 2 5f r o mS w e d e n
and 125 from the UK. Their country-specific gender
distribution, median age, median disease duration and
educational background are summarised in Table 1.
Individual country fit
Initially the data from each country was fitted to the
Rasch model separately (Table 2). Local dependency was
observed within each domain, and so the 39 items were
grouped into 7 domains (testlets) and re-analysed. Fit to
the Rasch model was then satisfied in each country
including unidimensionality, with the exception of
Portugal, where marginal multi-dimensionality was
observed. An analysis of differential item functioning
showed absence of bias for age, gender, educational
level and disease duration across all countries except
Spain, where two items (movement and feelings) showed
bias for gender and disease duration.
Pooled data
Initial Rasch analysis of the 39 items from the pooled
data revealed significant deviations from the expecta-
tions of the Rasch model (X
2 = 977.055, DF = 351,
p = 0.000) and a high reliability (PSI = 0.976) (Table 2).
Item fit residuals had a mean of 1.018 (SD = 4.014) and
person fit residuals had a mean of 0.552 (SD = 2.554).
Nine items displayed fit residuals values outside the ±
2.5 expected range and a probability less than the Bon-
ferroni adjusted a-value of 0.0013 indicating significant
deviation from the model.
The patterns of the items’ thresholds were examined
and 5/39 items displayed borderline disordering. These
items were: 1) Using acupuncture, ultrasound or hydro-
therapy (pain) 2) Devices which would help me do prac-
tical things (Movement) 3) Why I am feeling down or
depressed (Feelings) 4) How arthritis might affect my
children or relatives (Arthritis process) 5) Times when I
should call the doctor or nurse (Self-help measures).
Examination of the category probability curves for the
above items indicated the need to amalgamate two
categories “al i t t l ei m p o r t a n t ” and “fairly important” for
all the five items. A trial rescoring improved the thresh-
old ordering but the overall fit worsened, therefore the
category structures of these items were not re-scored.
Local dependency and unidimensionality
Examination of the person-item residual correlation
matrix revealed that most domain-specific items were
Table 1 Sample characteristics by country
Finland The Netherlands Norway Portugal Spain Sweden UK Total
Sample size 135 165 137 123 230 125 125 1042
Percentage of females (%) 82.2 88.5 73.7 71.5 75.2 76.0 79.2 78.0
Median age (years) 54 67 57 52 58 61 58
Median disease duration (years) 10 12 7 11 10 15 13
Basic education (n) 53 29 105 67 111 50 105 473
Higher education (n) 81 134 32 47 104 73 17 488
Ndosi et al. BMC Musculoskeletal Disorders 2011, 12:110
http://www.biomedcentral.com/1471-2474/12/110
Page 3 of 9locally dependent and this was significantly affecting the
fit to the model. All domain-specific items were then
amalgamated into a testlet (each testlet corresponding
to one ENAT domain) and the ENAT was then re-
analysed as a seven-testlet scale which showed an accep-
table fit to the Rasch model (X
2 = 71.909; DF = 63;
p = 0.207) (Table 2 and Table 3). The strict unidimen-
sionality test revealed the proportion of significant
t-tests to be 0.048 (95%CI = 0.034 - 0.063) confirming
its unidimensionality. The reliability of the final ENAT
was excellent (PSI = 0.951). All analyses were thereafter
based on the domain (testlet) scores. The person-item
threshold distribution indicated that only a small
proportion of the sample was above the range of the
measurement indicating the ability of the ENAT to cap-
ture well the educational needs of patients (Figure 1).
Differential item functioning
Following fit to the Rasch model, DIF analysis on the
pooled data revealed DIF by gender, age, disease dura-
tion, educational background and by country. However,
apart from domain 3 (feelings) which displayed a
non-uniform DIF by gender, all the DIF was uniform.
Post-hoc analyses revealed that the cross-cultural DIF
was the most significant contributing factor.
The Dutch data alone contributed to DIF by country
on 4 testlets (pain, feelings, treatments and support).
Splitting for DIF by country resolved all the cross-
cultural DIF and most other sources of DIF. Testlet 2
(movement) continued to display uniform DIF by gen-
der and by disease duration, while testlet 6 (self-help
measures) had borderline DIF by educational
background.
Calibration of the ENAT into an interval scale
Following the adjustment for the cross-cultural DIF, the
ENAT maintained a good fit to the Rasch model (X
2 =
138.311, DF = 162, p = 0.214) and an excellent reliability
(PSI = 0.951). The ENAT domain raw scores were
mapped against the corresponding Rasch transformed
scores (in logits) and were linearly transformed to
Table 2 Rasch analysis results
Item Fit Residual Person Fit Residual Chi Square Interaction PSI Independent
T-Tests (CI)
Analysis Mean SD Mean SD Value (DF) p N
UK Analysis1 (initial) 0.34 1.686 -0.269 2.008 442.439 (351) 0.000 0.972 119 0.218 (0.179-0.258)
Analysis 2 (Subtest) 0.541 0.699 -0.308 1.168 7.116 (7) 0.417 0.947 119 0.068 (0.028 - 0.107)
The Netherlands Analysis1 (initial) 0.294 1.669 -0.393 2.285 130.721 (78) 0.000 0.967 163 0.215 (0.181 -0.249)
Analysis 2 (Subtest) 0.433 1.365 -0.335 1.235 14.511 (14) 0.412 0.944 153 0.042 (0.006 - 0.078)
Finland Analysis1 (initial) 0.190 1.611 -0.347 2.195 94.144 (39) 0.000 0.961 133 0.215 (0.178 - 0.253)
Analysis 2 (Subtest) 0.333 1.037 -0.364 1.342 14.977 (14) 0.380 0.900 130 0.078 (0.040 - 0.116)
Norway Analysis1 (initial) 0.171 1.438 -0.393 2.025 73.617 (39) 0.001 0.965 133 0.235 (0.198-0.272)
Analysis 2 (Subtest) 0.542 0.873 -0.357 1.150 6.053 (7) 0.534 0.919 131 0.056 (0.018-0.094)
Portugal Analysis1 (initial) 0.426 1.355 -0.515 2.624 56.025 (39) 0.038 0.985 114 0.211 (0.171-0.251)
Analysis 2 (Subtest) 0.309 0.901 -0.449 1.337 2.625 (7) 0.917 0.975 114 0.105 (0.065 - 0.145)
Spain Analysis1 (initial) 0.610 2.531 -0.351 2.485 781.797 (351) 0.000 0.981 187 0.214 (0.183 - 0.245)
Analysis 2 (Subtest) 0.544 0.854 -0.375 1.293 17.450 (14) 0.233 0.963 186 0.022 (-0.010 - 0.053)
Sweden Analysis1 (initial) 0.307 1.377 -0.248 2.032 93.612 (39) 0.000 0.972 119 0.303 (0.263 - 0.342)
Analysis 2 (Subtest) 0.406 0.941 -0.322 1.146 5.409 (7) 0.610 0.944 118 0.061 (0.021 - 0.101)
Pooled Analysis1 (initial) 1.018 4.014 -0.552 2.554 977.055 (351) 0.000 0.976 968 0.185 (0.171 - 0.198)
Analysis 2 (Subtest) 0.847 1.475 -0.466 1.381 71.909 (63) 0.207 0.951 951 0.048 (0.034 - 0.063)
Expected values for a perfect model fit 0 1 0 1 > 0.05 > 0.85 0.05 (or Lower CI <0.05)
SD = Standard deviation, DF = Degrees of freedom, P = Χ
2 probability, (significant P = item misfit), PSI = Person
separation index, CI = Confidence intervals
Table 3 Item (testlet) fit
Item Location SE Fit
residual
DF Χ
2 P
Pain 0 0.010 0.176 743.47 3.748 0.927
Movement 0.014 0.010 -0.304 784.07 12.637 0.179
Feelings 0.097 0.011 3.760 775.61 14.563 0.104
Arthritis process -0.139 0.009 -0.309 756.16 13.326 0.148
Treatments -0.061 0.009 1.843 762.92 7.538 0.581
Self-help
measures
-0.060 0.010 0.274 769.69 9.104 0.428
Support systems 0.149 0.012 0.490 773.07 10.992 0.276
SE = Standard error, DF = Degrees of freedom, Χ
2 = Chi Square statistic, P =
Χ
2 probability (significant P = item misfit)
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(Table 4). A separate DIF-adjusted table was calibrated
for the Dutch cohort (Table 5).
Discussion
This study has demonstrated that the ENAT satisfies
Rasch model expectation in seven countries, with the
possible exception of marginal multidimensionality in
Portugal. The ENAT has been shown to be largely
invariant by age, gender, educational level and disease
duration with each country. When data were pooled,
some DIF manifested, but was largely driven by coun-
try-specific DIF. When examined, most DIF was shown
to cancel, but country DIF remained. Consequently
when data are pooled across countries, adjustment must
be made to accommodate the potential bias. Following
such an adjustment, an interval scale transformation can
be made, giving a raw-score interval metric table for
general use.
A number of issues have arisen from this work. The
breach of the local independence assumption has been
shown to drive misfit to the Rasch model. This can be
accommodated through the testlet design. This deals
with the perennial problem of the tension between the
clinimetric needs and the psychometric requirements of
a measure when items that have clinical relevance are
removed from the scale [39-41]. Leaving the items in
the scale is advantageous in that the items may inform
practitioners about educational needs at the finer level,
while grouping them into testlets effectively accounts
for the local dependence so satisfying the psychometric
requirements [42].
The second issue is the implication of the lack
of invariance across countries for pooling data in interna-
tional studies. DIF analysis revealed that the cross-cultural
DIF was responsible for most of the non-invariance in the
data. Cross-cultural adjustment involved splitting the DIF-
affected items by country, producing a scale with both etic
(culturally-general) and emic (culturally-specific) items.
This permits the scale to be culturally relevant while per-
mitting comparisons across cultures and languages on the
basis of the common etic items. Once the cross-cultural
invariance was adjusted, the overall DIF improved includ-
ing resolution of the non-uniform DIF by gender. When
cross-cultural comparisons are to be performed, a separate
DIF-adjusted conversion table for the emic data will need
to be used. However, it should be stated that the magni-
tude of the observed DIF was only marginal, in that the
maximum difference of location across countries within
any educational need level (class interval) was only 0.18
logits. This suggests that the sample size of the pooled
data was driving the statistical significance, and that the
observed magnitude of DIF is below the level considered
to be associated with measurement error [43].
As such, the ENAT can be used as a routine clinical
checklist or as a research (or an audit) tool. In the
Figure 1 Person-item threshold distribution.
Ndosi et al. BMC Musculoskeletal Disorders 2011, 12:110
http://www.biomedcentral.com/1471-2474/12/110
Page 5 of 9former use, the clinician can use the ENAT as a simple
checklist to assess perceived educational needs of
patients before a clinic consultation. In this context, the
perceived priority needs can be determined by looking
at the completed ENAT without the need for scoring. In
the latter use (measurement context) where the underly-
ing latent construct of “educational need” is important,
the Rasch-transformed scores give a common metric
across all domains for comparative purposes. All
domains contribute to measuring a single construct;
thus adding up the domain scores is a sufficient statistic
for estimating patients’ educational needs (range = 0
to 156).
While the ENAT provides patients’ perceived educa-
tion needs, the health professional may know more
about current treatment options and guidelines such as
treat-to-target recommendations [44] which are benefi-
cial to the patients. Having assessed patient’s perceived
educational priorities using the ENAT, the health
professional can then discuss the needs arising with
the patient, and provide more information about the
available treatment goals and options in order to facili-
tate patient participation in their management. The
main limitation of this study is that the ENAT is a
self-completed questionnaire and consequently it did
not reach the population of patients who cannot read
and write. Further investigation of the marginal multi-
dimensionality in Portugal would also be required. The
ENAT can be obtained by contacting the correspond-
ing author.
Table 4 Conversion of raw ENAT domain scores to Rasch-transformed values.
Raw Score Rasch transformed score
Pain Movement Feelings Arthritis Treatments Self-help Support
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1.0 2.7 1.9 1.8 2.1 2.2 1.5 1.8
2.0 4.5 3.1 3.1 3.6 3.6 2.7 3.0
3.0 5.6 4.1 4.0 4.6 4.6 3.6 4.0
4.0 6.6 4.8 4.8 5.4 5.6 4.3 4.8
5.0 7.3 5.6 5.7 6.2 6.3 5.0 5.5
6.0 8.1 6.2 6.3 6.9 7.1 5.5 6.1
7.0 8.7 6.8 7.0 7.5 7.8 6.1 6.8
8.0 9.3 7.4 7.7 8.2 8.4 6.8 7.5
9.0 9.9 8.1 8.3 8.9 9.1 7.5 8.1
10.0 10.5 8.7 9.0 9.5 9.8 8.2 8.9
11.0 11.1 9.3 9.7 10.3 10.4 9.1 9.6
12.0 11.6 10.0 10.5 11.2 11.3 10.2 10.4
13.0 12.2 10.7 11.4 12.0 12.1 11.3 11.3
14.0 12.8 11.5 12.5 13.0 13.1 12.4 12.3
15.0 13.4 12.3 13.9 13.9 14.1 13.5 13.9
16.0 14.1 13.1 16.0 15.1 14.9 14.4 16.0
17.0 14.6 14.3 15.9 15.9 15.3
18.0 15.3 15.5 16.9 16.7 16.2
19.0 16.1 17.4 17.7 17.4 17.1
20.0 17.0 20.0 18.4 18.2 18.0
21.0 17.9 19.2 19.0 18.9
22.0 19.3 20.0 19.7 20.0
23.0 21.1 20.8 20.5 21.7
24.0 24.0 21.6 21.3 24.0
25.0 22.6 22.3
26.0 23.9 23.7
27.0 25.6 25.3
28.0 28.0 28.0
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While Patient education is recommended as an integral
part of rheumatic diseases management, [6,7] knowing
what aspect of education may be required by a patient
at any specific point of their treatment is an essential
prerequisite to ensure that such needs are met. The
ENAT offers a simple tool to help professionals judge
what is required. It satisfied the strictest standards of
measurement in all but Portugal, where marginal multi-
dimensionality was observed, and can offer interval scal-
ing when required. The scale can be used with
confidence within the countries studied, but if data are
to be pooled, then this will require adjustment within
the framework of the Rasch measurement model, so
providing the ability to compare educational needs
across Europe.
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